NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.84 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.84 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 51 |
Immunovant Inc
NASDAQ:IMVT |
% | $6.29 Billion | Healthcare | Biotechnology | $30.47 | +0.69% |
| 52 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
% | $6.10 Billion | Healthcare | Biotechnology | $39.43 | -0.10% |
| 53 |
Immunitybio Inc
NASDAQ:IBRX |
% | $5.96 Billion | Healthcare | Biotechnology | $10.51 | +6.05% |
| 54 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
% | $5.84 Billion | Healthcare | Biotechnology | $90.78 | +1.27% |
| 55 |
Erasca Inc
NASDAQ:ERAS |
% | $5.61 Billion | Healthcare | Biotechnology | $16.03 | +3.69% |
| 56 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
% | $5.39 Billion | Healthcare | Biotechnology | $63.82 | +0.89% |
| 57 |
PTC Therapeutics Inc
NASDAQ:PTCT |
% | $5.37 Billion | Healthcare | Biotechnology | $64.70 | +3.42% |
| 58 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
% | $5.24 Billion | Healthcare | Biotechnology | $86.01 | +5.73% |
| 59 |
Crispr Therapeutics AG
NASDAQ:CRSP |
% | $5.15 Billion | Healthcare | Biotechnology | $53.39 | +5.85% |
| 60 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
% | $5.09 Billion | Healthcare | Biotechnology | $143.73 | +2.73% |
| 61 |
Cogent Biosciences Inc
NASDAQ:COGT |
% | $5.03 Billion | Healthcare | Biotechnology | $31.00 | +3.06% |
| 62 |
Travere Therapeutics Inc
NASDAQ:TVTX |
% | $4.91 Billion | Healthcare | Biotechnology | $52.13 | +0.16% |
| 63 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
% | $4.55 Billion | Healthcare | Biotechnology | $14.49 | +0.00% |
| 64 |
Akero Therapeutics Inc
NASDAQ:AKRO |
% | $4.50 Billion | Healthcare | Biotechnology | $54.65 | +0.00% |
| 65 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
% | $4.30 Billion | Healthcare | Biotechnology | $42.19 | -0.02% |
| 66 |
Tango Therapeutics Inc
NASDAQ:TNGX |
% | $4.01 Billion | Healthcare | Biotechnology | $23.81 | +5.49% |
| 67 |
Indivior PLC Ordinary Shares
NASDAQ:INDV |
% | $3.91 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $35.83 | +1.07% |
| 68 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA |
% | $3.85 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $79.78 | +1.31% |
| 69 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
% | $3.66 Billion | Healthcare | Biotechnology | $39.06 | -0.43% |
| 70 |
Legend Biotech Corp
NASDAQ:LEGN |
% | $3.62 Billion | Healthcare | Biotechnology | $18.62 | -0.48% |
| 71 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX |
% | $3.57 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $12.18 | +2.01% |
| 72 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
% | $3.54 Billion | Healthcare | Biotechnology | $46.99 | +0.00% |
| 73 |
Abcellera Biologics Inc
NASDAQ:ABCL |
% | $3.53 Billion | Healthcare | Biotechnology | $12.55 | +4.37% |
| 74 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
% | $3.48 Billion | Healthcare | Biotechnology | $36.11 | +0.14% |
| 75 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
% | $3.41 Billion | Healthcare | Biotechnology | $19.78 | +1.02% |
| 76 |
GRAIL, LLC
NASDAQ:GRAL |
% | $3.40 Billion | Healthcare | Diagnostics & Research | $140.58 | +6.01% |
| 77 |
Veracyte Inc
NASDAQ:VCYT |
% | $3.38 Billion | Healthcare | Diagnostics & Research | $45.23 | +3.74% |
| 78 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
% | $3.21 Billion | Healthcare | Biotechnology | $73.16 | +1.30% |
| 79 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
% | $3.14 Billion | Healthcare | Biotechnology | $28.14 | +3.46% |
| 80 |
Denali Therapeutics Inc
NASDAQ:DNLI |
% | $3.11 Billion | Healthcare | Biotechnology | $19.45 | +4.18% |
| 81 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
% | $3.07 Billion | Healthcare | Biotechnology | $26.58 | +8.53% |
| 82 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
% | $3.00 Billion | Healthcare | Biotechnology | $40.98 | +0.86% |
| 83 |
Relay Therapeutics Inc
NASDAQ:RLAY |
% | $2.95 Billion | Healthcare | Biotechnology | $17.88 | +2.70% |
| 84 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
% | $2.82 Billion | Healthcare | Biotechnology | $36.44 | +0.77% |
| 85 |
Zai Lab Ltd
NASDAQ:ZLAB |
% | $2.81 Billion | Healthcare | Biotechnology | $24.99 | +0.73% |
| 86 |
Dyne Therapeutics Inc
NASDAQ:DYN |
% | $2.75 Billion | Healthcare | Biotechnology | $16.64 | +1.65% |
| 87 |
Beam Therapeutics Inc
NASDAQ:BEAM |
% | $2.60 Billion | Healthcare | Biotechnology | $25.70 | +4.47% |
| 88 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN |
% | $2.48 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $42.67 | +1.26% |
| 89 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
% | $2.45 Billion | Healthcare | Biotechnology | $21.58 | +1.48% |
| 90 |
Precigen Inc
NASDAQ:PGEN |
% | $2.43 Billion | Healthcare | Biotechnology | $7.81 | +2.76% |
| 91 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
% | $2.43 Billion | Healthcare | Biotechnology | $26.49 | +1.53% |
| 92 |
Disc Medicine Inc.
NASDAQ:IRON |
% | $2.38 Billion | Healthcare | Biotechnology | $62.06 | +2.12% |
| 93 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
% | $2.35 Billion | Healthcare | Biotechnology | $40.28 | +1.72% |
| 94 |
89bio Inc
NASDAQ:ETNB |
% | $2.20 Billion | Healthcare | Biotechnology | $14.84 | +0.00% |
| 95 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX |
% | $2.17 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $8.55 | +3.14% |
| 96 |
Vera Therapeutics Inc
NASDAQ:VERA |
% | $2.14 Billion | Healthcare | Biotechnology | $29.88 | +0.50% |
| 97 |
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
% | $2.14 Billion | Healthcare | Biotechnology | $16.65 | +2.65% |
| 98 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
% | $2.12 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $21.64 | +0.05% |
| 99 |
ADMA Biologics Inc
NASDAQ:ADMA |
% | $2.12 Billion | Healthcare | Biotechnology | $10.36 | +0.29% |
| 100 |
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS |
% | $2.07 Billion | Healthcare | Biotechnology | $23.37 | +4.42% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices